Status:
TERMINATED
Combining LHu With Ultrasound Monitoring in IUI
Lead Sponsor:
Clinique Ovo
Conditions:
Infertility
Eligibility:
FEMALE
18-39 years
Phase:
NA
Brief Summary
Intra-uterine insemination (IUI), generally in combination with ovarian stimulation, is one of the most commonly used treatments for infertility. Accurate timing of insemination, in order to coincide ...
Eligibility Criteria
Inclusion
- Undergoing IUI treatments for:
- Unexplained infertility (including endometriosis stage 1-2)
- Mild male factor (\>5x106/ml motile sperm as determined by total sperm concentration x % A+B motility in the latest spermogram)
- Donor insemination
- Natural or stimulated cycles with clomiphene citrate or letrozole
- At least 1 patent tube on hysterosalpingogram, hysterosonogram or laparoscopy within the last two years
- Antral follicular count ≥10 and FSH\<10
Exclusion
- Polycystic ovarian syndrome or any cause of oligo or anovulation
- Patients taking other infertility medication (metformin, 17B estradiol, progesterone or gonadotropins)
- Presence of an ovarian cyst or a follicle \>20 mm on the first ultrasound or any reason for immediate HCG administration
- A previous sperm washing result with less than 5x106/ml motile sperm
- Previous inconclusive uLH test or inability to perform uLH testing
Key Trial Info
Start Date :
November 15 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2016
Estimated Enrollment :
367 Patients enrolled
Trial Details
Trial ID
NCT01205555
Start Date
November 15 2010
End Date
August 18 2016
Last Update
July 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ovo Fertilité
Montreal, Quebec, Canada, H2P 2S4